BioNTech SE (BNTX)
89.27
-0.04
(-0.04%)
USD |
NASDAQ |
Mar 20, 16:00
89.80
+0.53
(+0.59%)
After-Hours: 20:00
BioNTech Research and Development Expense (Quarterly) : 588.25M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| GSK Plc | 3.112B |
| Merck & Co., Inc. | 2.499B |
| Novavax, Inc. | 73.98M |
| Novo Nordisk A/S | 2.283B |
| Moderna, Inc. | 708.00M |